Latin American consensus: children born small for gestational age

Vista sencilla de ítem
dc.contributor.authorBoguszewski, Margaret CS
dc.contributor.authorBergada, Ignacio
dc.contributor.authorGunczler, Peter
dc.contributor.authorOrtiz, Teresa
dc.contributor.authorLlano, Mauricio
dc.contributor.authorDomené, Horacio M.
dc.contributor.authorCalzada-León, Raúl
dc.contributor.authorBlanco, Armando
dc.contributor.authorBarrientos, Margarita
dc.contributor.authorLanes, Roberto
dc.contributor.authorJaramillo, Orlando
dc.contributor.authorMericq, Verónica
dc.contributor.authorDamiani, Durval
dc.contributor.authorBelgorosky, Alicia
dc.contributor.authorProcel, Patricio
dc.date.accessioned2019-07-29T16:43:51Z
dc.date.available2019-07-29T16:43:51Z
dc.date.issued2015
dc.description.abstractenglishBackground Children born small for gestational age (SGA) experience higher rates of morbidity and mortality than those born appropriate for gestational age. In Latin America, identification and optimal management of children born SGA is a critical issue. Leading experts in pediatric endocrinology throughout Latin America established working groups in order to discuss key challenges regarding the evaluation and management of children born SGA and ultimately develop a consensus statement. Discussion SGA is defined as a birth weight and/or birth length greater than 2 standard deviations (SD) below the population reference mean for gestational age. SGA refers to body size and implies length-weight reference data in a geographical population whose ethnicity is known and specific to this group. Ideally, each country/region within Latin America should establish its own standards and make relevant updates. SGA children should be evaluated with standardized measures by trained personnel every 3 months during year 1 and every 6 months during year 2. Those without catch-up growth within the first 6 months of life need further evaluation, as do children whose weight is ≤ -2 SD at age 2 years. Growth hormone treatment can begin in SGA children > 2 years with short stature (< -2.0 SD) and a growth velocity < 25th percentile for their age, and should continue until final height (a growth velocity below 2 cm/year or a bone age of > 14 years for girls and > 16 years for boys) is reached. Blood glucose, thyroid function, HbA1c, and insulin-like growth factor-1 (IGF-1) should be monitored once a year. Monitoring insulin changes from baseline and surrogates of insulin sensitivity is essential. Reduced fetal growth followed by excessive postnatal catch-up in height, and particularly in weight, should be closely monitored. In both sexes, gonadal function should be monitored especially during puberty. Summary Children born SGA should be carefully followed by a multidisciplinary group that includes perinatologists, pediatricians, nutritionists, and pediatric endocrinologists since 10% to 15% will continue to have weight and height deficiency through development and may benefit from growth hormone treatment. Standards/guidelines should be developed on a country/region basis throughout Latin America.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1186/1471-2431-11-66
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn1471-2431
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/1573
dc.language.isoeng
dc.publisherBiomed Centralspa
dc.publisher.journalBMC Pediatricsspa
dc.relation.ispartofseriesBMC Pediatrics, 1471-2431, Vol. 11,Nro.66 2015, p.1-10spa
dc.relation.urihttps://bmcpediatr.biomedcentral.com/articles/10.1186/1471-2431-11-66
dc.rightsAttribution 4.0 International*
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf458
dc.rights.creativecommons2011
dc.rights.localAcceso abiertospa
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.decsHormona del crecimientospa
dc.subject.decsEdad gestacionalspa
dc.subject.decsEndocrinologíaspa
dc.subject.decsPediatríaspa
dc.subject.keywordsGrowth hormonespa
dc.subject.keywordsGrowth hormone treatmentspa
dc.subject.keywordsGrowth hormone therapyspa
dc.subject.keywordsAcanthosis nigricansspa
dc.titleLatin American consensus: children born small for gestational agespa
dc.typearticlespa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localartículospa

Archivos

Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Boguszewski M.C.S., Mericq V., Bergada I., Damiani D., Belgorosky A., Gunczler P._2011.pdf
Tamaño:
478.64 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos